These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21921531)

  • 21. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
    J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF tap test - Obsolete or appropriate test for predicting shunt responsiveness? A systemic review.
    Mihalj M; Dolić K; Kolić K; Ledenko V
    J Neurol Sci; 2016 Mar; 362():78-84. PubMed ID: 26944123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
    Agren-Wilsson A; Lekman A; Sjöberg W; Rosengren L; Blennow K; Bergenheim AT; Malm J
    Acta Neurol Scand; 2007 Nov; 116(5):333-9. PubMed ID: 17922727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH).
    Patel M; Zhang Y; Xiao MF; Worley P; Moghekar A
    Neurol Neurochir Pol; 2024; 58(1):47-53. PubMed ID: 38393959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study.
    Lee JH; Park DH; Back DB; Lee JY; Lee CI; Park KJ; Kang SH; Cho TH; Chung YG
    Med Sci Monit; 2012 Dec; 18(12):PR19-25. PubMed ID: 23197244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
    Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
    J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic volumetric analysis predicts response to CSF drainage and outcome to shunt surgery in idiopathic normal pressure hydrocephalus.
    Wu D; Moghekar A; Shi W; Blitz AM; Mori S
    Eur Radiol; 2021 Jul; 31(7):4972-4980. PubMed ID: 33389035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus.
    McGirt MJ; Woodworth G; Coon AL; Thomas G; Williams MA; Rigamonti D
    Neurosurgery; 2005 Oct; 57(4):699-705; discussion 699-705. PubMed ID: 16239882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus.
    Tarnaris A; Toma AK; Chapman MD; Keir G; Kitchen ND; Watkins LD
    J Neurosurg; 2011 Jul; 115(1):145-50. PubMed ID: 21438653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supplementary Tests in Idiopathic Normal Pressure Hydrocephalus: A Single-Center Experience with a Combined Lumbar Infusion Test and Tap Test.
    Raneri F; Zella MAS; Di Cristofori A; Zarino B; Pluderi M; Spagnoli D
    World Neurosurg; 2017 Apr; 100():567-574. PubMed ID: 28089835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid drainage and dynamics in the diagnosis of normal pressure hydrocephalus.
    Woodworth GF; McGirt MJ; Williams MA; Rigamonti D
    Neurosurgery; 2009 May; 64(5):919-25; discussion 925-6. PubMed ID: 19404152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical comorbidities correlated with a response to the cerebrospinal fluid tap test in idiopathic normal-pressure hydrocephalus.
    Naito H; Sugimoto T; Kimoto K; Abe T; Kawano T; Matsuoka C; Ohno N; Giga M; Kono T; Ueno H; Nomura E
    J Neurol Sci; 2021 Nov; 430():120024. PubMed ID: 34627053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
    Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
    Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus.
    Kamohara C; Nakajima M; Kawamura K; Akiba C; Ogino I; Xu H; Karagiozov K; Arai H; Miyajima M
    Acta Neurol Scand; 2020 Dec; 142(6):623-631. PubMed ID: 32619270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of cerebrospinal fluid tap-related oscillatory activity and shunt outcome in idiopathic normal-pressure hydrocephalus.
    Ikeda S; Kazui H; Tanaka T; Ishii R; Aoki Y; Hata M; Canuet L; Yoshiyama K; Iwase M; Pascual-Marqui R; Takeda M
    Psychogeriatrics; 2015 Sep; 15(3):191-7. PubMed ID: 25913881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disability risk or unimproved symptoms following shunt surgery in patients with idiopathic normal-pressure hydrocephalus: post hoc analysis of SINPHONI-2.
    Yamada S; Kimura T; Jingami N; Atsuchi M; Hirai O; Tokuda T; Miyajima M; Kazui H; Mori E; Ishikawa M;
    J Neurosurg; 2017 Jun; 126(6):2002-2009. PubMed ID: 27419822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes after ventriculoatrial shunting for idiopathic normal pressure hydrocephalus.
    Liu A; Sankey EW; Jusué-Torres I; Patel MA; Elder BD; Goodwin CR; Hoffberger J; Lu J; Rigamonti D
    Clin Neurol Neurosurg; 2016 Apr; 143():34-8. PubMed ID: 26895207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.